Review Article: Pitavastatin: Similarities and Differences Compared with Other Statins
| dc.authorid | 336816 | en_US |
| dc.contributor.author | Faikoğlu, Gökhan | |
| dc.contributor.author | .;, ve diğer | |
| dc.date.accessioned | 2021-12-23T12:22:24Z | |
| dc.date.available | 2021-12-23T12:22:24Z | |
| dc.date.issued | 2021 | |
| dc.department | İstanbul Beykent Üniversitesi | en_US |
| dc.description.abstract | Dyslipidemia is the leading cause of cardiovascular mortality and morbidity. Reduction of lipids, particularly low-density lipoprotein cholesterol (LDL-C), with statins, significantly decreases the risk of cardiovascular events. Among different statins, pitavastatin, exhibits a peculiar pharmacokinetic and pharmacological profile. Indeed, differently from other statins, pitavastatin: a) is not metabolized by hepatic cytochrome CYP3A4 isoenzyme, therefore has a very low drug-drug interaction; b) has a similar or greater effect on LDL-C, c) is not associated with glucose metabolism impairment, and the risk of new onset diabetes is very low, d) increases high density lipoproteins (HDL) levels and, particularly, improves cholesterol efflux capacity of HDL, d) decreases cardiovascular outcome in primary and secondary prevention. | en_US |
| dc.identifier.citation | Acta Pharmaceutica Sciencia Vol 59:(4), 2021 | en_US |
| dc.identifier.doi | 10.23893/1307-2080.APS.05935 | |
| dc.identifier.issn | 1302-3284 | |
| dc.identifier.scopus | 2-s2.0-85117916640 | en_US |
| dc.identifier.scopusquality | N/A | en_US |
| dc.identifier.uri | https://doi.org/10.23893/1307-2080.APS.05935 | |
| dc.indekslendigikaynak | Scopus | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Istanbul Medipol University | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.subject | Dyslipidemia | en_US |
| dc.subject | HDL | en_US |
| dc.subject | New-onset diabetes | en_US |
| dc.subject | Pitavastatin | en_US |
| dc.subject | Statins | en_US |
| dc.title | Review Article: Pitavastatin: Similarities and Differences Compared with Other Statins | en_US |
| dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- 44 Review article Pitavastatin Similarities and differences compared with other statins.pdf
- Boyut:
- 536 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
Lisans paketi
1 - 1 / 1
Küçük Resim Yok
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama:
